HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group

MLA

S. Bain, et al. “HER-2 Overexpression Is an Independent Marker of Poor Prognosis of Advanced Primary Ovarian Carcinoma: A Multicenter Study of the GINECO Group.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 15, no. 1, Dec. 2003. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1cf8e11a46e784964a4ad0bd59d43055&authtype=sso&custid=ns315887.

APA

S. Bain, B. Leduc, Sophie Camilleri-Broët, A Le Tourneau, Josée Audouin, H. Orfeuvre, O. Levrel, D. Paraiso, Anne-Claire Hardy-Bessard, & Eric Pujade-Lauraine. (2003). HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 15(1).

Chicago

S. Bain, B. Leduc, Sophie Camilleri-Broët, A Le Tourneau, Josée Audouin, H. Orfeuvre, O. Levrel, D. Paraiso, Anne-Claire Hardy-Bessard, and Eric Pujade-Lauraine. 2003. “HER-2 Overexpression Is an Independent Marker of Poor Prognosis of Advanced Primary Ovarian Carcinoma: A Multicenter Study of the GINECO Group.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 15 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1cf8e11a46e784964a4ad0bd59d43055&authtype=sso&custid=ns315887.